Global Glucagon Market Infographics Description:
- The global glucagon market was valued at US$ 461 Mn in 2019.
- Worldwide glucagon market is projected to reach US$ 837.0Mn in 2029 at a CAGR of 6.2% from 2020 to 2029.
- Amongst product types the kits glucagon type in the global glucagon market is estimated to account for a majority revenue share of 78.6% in 2019, owing to growing advancements in therapies & drugs and rising funding by leading organizations.
- Among all the application segments, the emergency use is expected to register the highest CAGR of over 6.3%, owing to the increasing pharmaceutical segment in an emerging nation
- North America market is expected to dominate the global glucagon market and is expected to account for the largest market revenue share as compared to that of markets in other regions.
- Companies profiled in the report are Novo Nordisk A/S, Eli Lilly & Co, Fresenius SE & Co. KGaA, Torrent Pharmaceuticals Ltd, Xeris Pharmaceuticals, Inc., Svar Life Science AB, Taj Pharmaceuticals Ltd.
